Literature DB >> 6381283

Histiocytosis X cells and Langerhans cells: enzyme histochemical and immunologic similarities.

J H Beckstead, G S Wood, R R Turner.   

Abstract

The proliferating cell in histiocytosis X has been thought to be an abnormal Langerhans cell since the identification in 1965 of the characteristic X-bodies morphologically identical to the Birbeck granules of epidermal Langerhans cells. This conclusion is based primarily on this finding and on morphologic similarities at the light microscopic level. Enzyme histochemical data have been somewhat conflicting and have not provided strong support for this conclusion. Recently, immunohistochemical studies have shown data consistent with a Langerhans cell origin for histiocytosis X cells. This study documents the presence of nonspecific esterase, acid phosphatase, and adenosine triphosphatase in both Langerhans cells and histiocytosis X cells. Both types of cells also react with antibodies directed against widely distributed leukocyte antigens (HLA-A,B,C; Ia; L3B12); Langerhans cell/thymocyte antigen [Leu 6(T6)]; histiocyte antigen (Leu-M3); helper T-cell/histiocyte antigen [Leu-3(T4)]; and S-100 protein. These results complement earlier immunologic studies and add enzyme histochemical data that strongly support the concept of histiocytosis X as a proliferative disorder of cells of Langerhans lineage.

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6381283     DOI: 10.1016/s0046-8177(84)80143-4

Source DB:  PubMed          Journal:  Hum Pathol        ISSN: 0046-8177            Impact factor:   3.466


  17 in total

1.  Cutaneous host defense in leishmaniasis: interaction of isolated dermal macrophages and epidermal Langerhans cells with the insect-stage promastigote.

Authors:  R M Locksley; F P Heinzel; J E Fankhauser; C S Nelson; M D Sadick
Journal:  Infect Immun       Date:  1988-02       Impact factor: 3.441

2.  Case report 615: Histiocytosis X (eosinophilic granuloma of the fibula).

Authors:  C J Thijn; A Martijn; A Postma; W M Molenaar
Journal:  Skeletal Radiol       Date:  1990       Impact factor: 2.199

3.  Case report 508: Histiocytosis X of the left femur-proximal segment.

Authors:  C P Adler; H E Schaefer
Journal:  Skeletal Radiol       Date:  1988       Impact factor: 2.199

4.  Unusual immunophenotype displayed by histiocytes in haemophagocytic lymphohistiocystosis.

Authors:  T Herlin; G Pallesen; T Kristensen; N Clausen
Journal:  J Clin Pathol       Date:  1987-12       Impact factor: 3.411

5.  Circulating human dendritic cells differentially express high levels of a 55-kd actin-bundling protein.

Authors:  G Mosialos; M Birkenbach; S Ayehunie; F Matsumura; G S Pinkus; E Kieff; E Langhoff
Journal:  Am J Pathol       Date:  1996-02       Impact factor: 4.307

6.  CD45 epitope mapping of human CD1a+ dendritic cells and peripheral blood dendritic cells.

Authors:  G S Wood; P S Freudenthal; A Edinger; R M Steinman; R A Warnke
Journal:  Am J Pathol       Date:  1991-06       Impact factor: 4.307

7.  Demonstration of phenotypic abnormalities of thymic epithelium in thymoma including two cases with abundant Langerhans cells.

Authors:  V B Kraus; E A Harden; B Wittels; J O Moore; B F Haynes
Journal:  Am J Pathol       Date:  1988-09       Impact factor: 4.307

8.  Multisystem Langerhans' cell histiocytosis with pancreatic involvement.

Authors:  R C Yu; A Attra; C M Quinn; T Krausz; A C Chu
Journal:  Gut       Date:  1993-04       Impact factor: 23.059

9.  Letterer-Siwe disease: immunohistochemical evidence for a proliferative disorder involving immature cells of Langerhans lineage.

Authors:  L P Ruco; D Remotti; F Monardo; S Uccini; M L Cristiani; A Modesti; C D Baroni
Journal:  Virchows Arch A Pathol Anat Histopathol       Date:  1988

10.  Cathepsin D and E co-expression in sinus histiocytosis with massive lymphadenopathy (Rosai-Dorfman disease) and Langerhans' cell histiocytosis: further evidences of a phenotypic overlap between these histiocytic disorders.

Authors:  M Paulli; A C Feller; E Boveri; S Kindl; E Berti; R Rosso; H Merz; F Facchetti; C Gambini; F Bonetti
Journal:  Virchows Arch       Date:  1994       Impact factor: 4.064

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.